Histology laboratory

CodeServicePrice, euroPrice, roub
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 14 867,89
H250 Histology of tumor surgical samples 389 27 153,09
H299 Intraoperative (urgent) histology and cytology 200 13 960,46
H270 Histology of breast wide local excision (lumpectomy) specimen 389 27 153,09
H271 Histology of mastectomy speciment 367 25 617,44
H272 Histology of sentinel lymph node with IHC if necessary 227 15 845,12
H273 Histology of lymph node dissection speciment 213 14 867,89
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 8 864,89
M202 Hystology with supplementary staining for helicobacter pylori 227 15 845,12
M203 Multiple histology 3 samples and more 344 24 011,99
H204 Histology of the prostate punctates 358 24 989,22
H205 Histology of scrapings of the uterus 213 14 867,89
H206 Histology of the mammary gland punctates 213 14 867,89
H207 Histology of liver bioptates 213 14 867,89
H208 Histology of CT-guideline needle biopsy 397 27 711,51
H209 Histology of skin (PUNCH-biopsy) 213 14 867,89
H210 Histology of skin tumors 198 13 820,86
H211 Histology of bone marrow patho bioptate 213 14 867,89
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 10 889,16
H231 Consultation with the making of histology specimens with paraffin blocks 224 15 635,72
H232 Consultation with the making of specimens and immunohistochemistry 358 24 989,22
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 27 153,09
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 6 421,81
CYTOLOGY
M300 Citology / 1 lame 75 5 235,17
M301 Cytologic cervical smear (Pap Smear) 94 6 561,42
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 5 444,58
Z303 Cytology of the mammary gland 75 5 235,17
Z304 Cytology of the thyroid gland punctate 117 8 166,87
Z305 Cytology of liquid 78 5 444,58
Z306 Cytology of endoscopic material 56 3 908,93
Z307 Cytology of scrapings from the surface of the skin and mucous 78 5 444,58
Z308 Cytology of surgical samples 78 5 444,58
Z309 Cytology of the lymph nodes punctate 94 6 561,42
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 5 444,58
Z312 Cytologic cervical smear by the method of liquid cytology with HPV Cobas4800 testing (PAP Smear +) 120 8 376,28
Z313 HPV high carcinogenic risk (Cobas4800) 67 4 676,75
IMMUNOHISTOCHEMISTRY
G023 Markers for dysplasia of cervix – p16, N33, MLH- in biopsy materials and PAP smears 167 11 656,98
G024 Markers for endometrial cancer – p16, RASSF1, MLH- in biopsy material 167 11 656,98
G027 Proliferation marker KI-67 for Breast Cancer (Immunohistochemistry) 89 6 212,40
G028 Breast Cancer Marker of basal-like phenotype CK 5/6 89 6 212,40
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 19 405,04
I002 Immunohistochemical differential diagnosis of tumors 389 27 153,09
I003 Immunohistochemistry of one marker panel differential diagnosis 89 6 212,40
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 31 899,65
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 198 13 820,86
GENETIC ANALYSIS
G117 Cytogenetiс study of bone marrow by FISH Method 156 10 889,16
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 27 920,92
I501 Cytogenetic study by hybridization in situ FISH / CISH (one tube) in sections from paraffin blocks 255 17 799,59
Z050 Determination of genotypes with high risk HPV by HPV Digene-Test (16, 18, 31, 33, 35,39,45,51,52,56,58,59,68) 65 4 537,15
Z051 Determination of genotypes of HPV low risk HPV by Digene-Test (6,11,42,43,44) 65 4 537,15
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 20 033,26
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 20 033,26
G202 EGFR gene amplification (sensitivity to cetuximab) 259 18 078,80
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 12 424,81
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 16 473,34
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 7 817,86
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 22 895,15
G207 Determination of the methylation status of the promoter body and MGMT gene 150 10 470,35
G275 BCAM gene activity in cancer of the thyroid gland (biopsy study) 159 11 098,57
G276 IL4 gene activity in cancer of the thyroid gland (biopsy study) 159 11 098,57
G277 IL10 gene activity in cancer of the thyroid gland (biopsy study) 159 11 098,57
G278 TG gene activity in cancer of the thyroid gland (biopsy study) 159 11 098,57
G279 Active genes BCAM, IL4, IL10, TG thyroid cancer (study biopsy) 229 15 984,73
G283 Activity GATA2 gene for prostate cancer (study biopsy) 159 11 098,57
G284 Activity IGF1 gene for prostate cancer (study biopsy) 159 11 098,57
G285 Activity IGF2 gene for prostate cancer (study biopsy) 159 11 098,57
G286 Activity IL4 gene for prostate cancer (study biopsy) 159 11 098,57
G287 Activity IL10 gene for prostate cancer (study biopsy) 159 11 098,57
G288 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (study biopsy) 252 17 590,18
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 249 17 380,77
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 17 380,77
I504 Translocation in synovial sarcoma SYT / SSX 249 17 380,77
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 249 17 380,77